Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016

Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016
Published Jul 30, 2016
28 pages — Published Jul 30, 2016
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016, provides in depth analysis on Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted pipeline therapeutics.

The report provides comprehensive information on the Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics development and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18)
- The report reviews Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics and enlists all their major and minor projects
- The report assesses Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18)
- Identify the use of drugs for target identification and drug repurposing
- Identify pote

  
Source:
Document ID
GMDHC0421TDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents22
  List of Tables31
  List of Figures31
Introduction41
  Global Markets Direct Report Coverage41
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Overview51
Therapeutics Development63
  Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Products under Development by Stage of Development61
  Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Products under Development by Therapy Area71
  Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Products under Development by Indication81
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Pipeline Products Glance91
  Early Stage Products91
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Products under Development by Companies102
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Products under Development by Universities/Institutes122
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Therapeutics Assessment144
  Assessment by Monotherapy/Combination Products141
  Assessment by Mechanism of Action152
  Assessment by Molecule Type171
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Companies Involved in Therapeutics Development182
  Selvita S.A.181
  Takeda Pharmaceutical Company Limited191
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Drug Profiles205
  BTZO-2 Drug Profile201
  HYCO-1 Drug Profile211
  SEL-303 Drug Profile221
  Small Molecule to Activate HO-1 for Endothelial Dysfunction, Asthma and Osteoarthritis Drug Profile231
  Small Molecules to Activate HO-1 Drug Profile241
Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) Dormant Projects252
Appendix272
  Methodology271
  Coverage271
  Secondary Research271
  Primary Research271
  Expert Panel Validation271
  Contact Us271
  Disclaimer281

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016" Jul 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Heme-Oxygenase-1-HO1-or-HMOX1-or-EC-1-14-14-18-Pipeline-Review-H2-2016-2088-16319>
  
APA:
Global Markets Direct - Market Research. (2016). Heme Oxygenase 1 (HO1 or HMOX1 or EC 1.14.14.18) - Pipeline Review, H2 2016 Jul 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Heme-Oxygenase-1-HO1-or-HMOX1-or-EC-1-14-14-18-Pipeline-Review-H2-2016-2088-16319>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.